July 12, 2016   ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc. announced today that the first commercial U.S. patient has received the Cartiva Synthetic Cartilage Implant (SCI) following its approval by the U.S. Food and Drug Administration (FDA) on July 1. The Cartiva SCI device is intended for use in the treatment of patients with painful arthritis at […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone